News & Resources

Olshan Advises Largest Stockholder of Pharmacyclics, Inc.

September 11, 2008

Olshan advised the largest Stockholder of Pharmacyclics, Inc. which announced successful negotiations resulting in four out of six board members of the board being replaced with the Stockholder's designees, thereby avoiding a proxy contest. Steve Wolosky and Adam W. Finerman represented the Stockholder.